Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-19 · Built: 2026-10-19 · 中文

← United States · Coverage record

US · SEC FORM 4

ImageneBio, Inc.

IMA · Nasdaq · CIK 0001835579 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

7 Form 4 transaction lines observed in the same window
2 sales · 5 option, withholding, award, gift or other lines

Last qualifying purchase2025-12-24 · SLATTERY JOSEPH P · $95.8K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesLow
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Yarema KristinChief Executive Officer
○○○
Lally Robert BPrincipal Accounting Officer
▼▼
Grant-Huerta YaninaChief Financial Officer
○
● Purchase▼ Sale○ Other

—

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-12-24 · SLATTERY JOSEPH P.

Recent Form 4 activity

1Purchases
2Sales
7Other Form 4 lines
7SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING2 sale line(s) · context only
OTHER5 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
32,852
Previous report
34,601
Avg daily volume
17,299
Days to cover
1.9

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2025-12-24SLATTERY JOSEPH PPurchase (P)Common Stock16,000USD 5.99USD 95,840SEC filing ↗
2025-07-25Stampacchia OtelloPurchase (P)Common Stock267,556USD 29.90USD 7,999,924SEC filing ↗
2025-07-25Bonita David PPurchase (P)Common Stock83,611USD 29.90USD 2,499,969SEC filing ↗
2022-06-24ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLCPurchase (P)Common Stock162,000USD 4.96USD 803,975SEC filing ↗
2022-06-24Bonita David PPurchase (P)Common Stock162,000USD 4.96USD 803,975SEC filing ↗
2022-06-23ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLCPurchase (P)Common Stock23,419USD 3.71USD 86,884SEC filing ↗
2022-06-23Bonita David PPurchase (P)Common Stock23,419USD 3.71USD 86,884SEC filing ↗
2022-06-22ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLCPurchase (P)Common Stock66,806USD 3.55USD 237,161SEC filing ↗
2022-06-22Bonita David PPurchase (P)Common Stock66,806USD 3.55USD 237,161SEC filing ↗
2021-03-30FORMELA JEAN FRANCOISPurchase (P)Common Stock125,000USD 16.00USD 2,000,000SEC filing ↗
2021-03-30Atlas Venture Associates Opportunity I, L.P.; Atlas Venture Associates Opportunity I, LLC; Atlas Venture Associates XI, L.P.; Atlas Venture Associates XI, LLC; Atlas Venture Fund XI, L.P.; Atlas Venture Opportunity Fund I, L.P.Purchase (P)Common Stock125,000USD 16.00USD 2,000,000SEC filing ↗
2021-03-30Bonita David PPurchase (P)Common Stock423,400USD 16.00USD 6,774,400SEC filing ↗
2021-03-30ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLCPurchase (P)Common Stock423,400USD 16.00USD 6,774,400SEC filing ↗
2021-03-30ORBIMED ADVISORS LLC; OrbiMed Capital GP VI LLC; OrbiMed Genesis GP LLCPurchase (P)Common Stock423,400USD 16.00USD 6,774,400SEC filing ↗
2021-03-30Bonita David PPurchase (P)Common Stock423,400USD 16.00USD 6,774,400SEC filing ↗

Form 4 evidence

10 transaction lines in the latest 365-day window; 84 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-14Yarema KristinAward / grant (A)Common Stock254,800USD 0.00USD 0SEC filing ↗
2026-08-14Grant-Huerta YaninaAward / grant (A)Common Stock104,000USD 0.00USD 0SEC filing ↗
2026-07-25Yarema KristinOption exercise / conversion (M)Common Stock38,376USD 0.00USD 0SEC filing ↗
Show recent Form 4 evidence (9 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-08-14Yarema KristinAward / grant (A)Common Stock254,800USD 0.00USD 0SEC filing ↗
2026-08-14Grant-Huerta YaninaAward / grant (A)Common Stock104,000USD 0.00USD 0SEC filing ↗
2026-07-25Yarema KristinOption exercise / conversion (M)Common Stock38,376USD 0.00USD 0SEC filing ↗
2026-07-25Yarema KristinJ (J)Common Stock115,129USD 0.00USD 0SEC filing ↗
2026-07-17Lally Robert BSale (S)Common Stock1,525USD 5.34USD 8,144SEC filing ↗
2026-07-16Lally Robert BSale (S)Common Stock1,671USD 5.50USD 9,190SEC filing ↗
2026-03-16Yarema KristinAward / grant (A)Common Stock85,400USD 0.00USD 0SEC filing ↗
2025-12-30Butler ErinAward / grant (A)Common Stock22,500USD 0.00USD 0SEC filing ↗
2025-12-24SLATTERY JOSEPH PPurchase (P)Common Stock16,000USD 5.99USD 95,840SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-19
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerIMA
CIK0001835579
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2836 Biological Products, (No Diagnostic Substances)
ExchangeNasdaq

Data coverage

Local Form 4 history84 transaction lines from 2021-03-30 to 2026-08-14
21 P purchase lines · 11 S sale lines · 52 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-19. Mapping status is an audit field and does not erase SEC filing evidence.